Elelyso® (taliglucerase alfa)
Full Name | Elelyso® (taliglucerase alfa) |
Drug | Elelyso |
Manufacturer | Pfizer |
Route of Administration | Intravenous |
Site of Care | Home or Healthcare Facility |
Approved Indication | Long-term enzyme replacement therapy (ERT) for adults with a confirmed diagnosis of Type 1 Gaucher disease |
Disease | Gaucher Type I Disease |
Therapeutic Area | Neurology, Genetics |
Enrollment Form Link | Enrollment Form |
Phone Number | 800-240-9572 |
Fax Number | 877-220-7581 |
Product Website | elelyso.pfizerpro.com |